Emil J. Freireich

33.6k citations
497 papers · 25.6k indexed · 7 hit papers · h-index 81
Topics
Acute Myeloid Leukemia Research (173 papers)Acute Lymphoblastic Leukemia research (114 papers)Chronic Lymphocytic Leukemia Research (85 papers)

In The Last Decade

Emil J. Freireich

493 papers receiving 23.4k citations

Hit Papers

Quantitative comparison of toxicity of anticancer agents ...1962202619832004196619831982200020002505007501000

Peers

Emil J. Freireich
Comparison fields: 5 of 176
  • Hematology 10.9k
  • Oncology 7.3k
  • Genetics 6.6k
  • Molecular Biology 6.0k
  • Public Health, Environmental and Occupational Health 5.0k
Replace Jack W. Singer with:
Jack W. Singer United States
Hillard M. Lazarus United States
Gerhard Ehninger Germany
Peter H. Wiernik United States
Bob Löwenberg Netherlands
Elihu H. Estey United States
Andrea Biondi Italy
Miguel Á. Sanz Spain
Martin S. Tallman United States
Frederick R. Appelbaum United States
Emil J. Freireich relative to Jack W. Singer United States Jack W. Singer's profile →
Citations per field
00.5×1.5×1.8×
Jack W. Singer · 1×
Citations per year

Countries citing papers authored by Emil J. Freireich

Since Specialization
Citations

This map shows the geographic impact of Emil J. Freireich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil J. Freireich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil J. Freireich more than expected).

Fields of papers citing papers by Emil J. Freireich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emil J. Freireich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil J. Freireich. The network helps show where Emil J. Freireich may publish in the future.

Co-authorship network of co-authors of Emil J. Freireich

This figure shows the co-authorship network connecting the top 25 collaborators of Emil J. Freireich. A scholar is included among the top collaborators of Emil J. Freireich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emil J. Freireich. Emil J. Freireich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 60
3
Chronic myelogenous leukemia--progress at the M. D. Anderson Cancer Center over the past two decades and future directions: first Emil J Freireich Award Lecture.
10
4
Molecular basis of oncology
13
5
Therapy of hematopoietic neoplasia
9
6
2-Chlorodeoxyadenosine: A new anticancer agent in lymphoid malignancies
3
7 28
8 14
9
Clinical sequence relationship between vinblastine and doxorubicin
1
10
Short-term sequential (S-TS) chemotherapy in young patients with acute myelogenous leukemia (AML)
2
11
Phase I--II study of 3-deazauridine in adults with acute leukemia.
7
12
Results of a phase II study of maytansine in patients with breast carcinoma and melanoma.
12
13
Increased remission rate and prolongation of survival in patients with soft tissue sarcomas treated with intensive chemotherapy on a protected environment prophylactic antibiotic program (PEPA)
6
14
Levamisole induced decline in lymphocyte content of cAMP among patients with solid tumors
1
15
Pulse cytophotometric analysis of cell cycle perturbation with bleomycin in vitro.
34
16 61
17
Electrocardiogram QRS voltage changes in adriamycin cardiomyopathy
5
18
Identification of smouldering leukemia by delaying chemotherapy
2
19 47
20
Clinical Studies of 6-Azauracil
31

About Emil J. Freireich

Emil J. Freireich is a scholar working on Hematology, Genetics and Oncology, having authored 497 papers that have together received 25.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (173 papers), Acute Lymphoblastic Leukemia research (114 papers) and Chronic Lymphocytic Leukemia Research (85 papers). The work is most often cited by research in Hematology (10.9k citations), Genetics (6.6k citations) and Oncology (7.3k citations). Emil J. Freireich has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Michael J. Keating, Hagop M. Kantarjian, Gerald P. Bodey, Kenneth B. McCredie, Elihu H. Estey, Emil Frei, Jörge E. Cortes, E. A. Gehan, Susan O’Brien and David P. Rall. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026